• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form DEFA14A filed by Pacific Biosciences of California Inc.

    5/20/25 5:26:51 PM ET
    $PACB
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Get the next $PACB alert in real time by email
    DEFA14A 1 a2025defa14a-additionalmat.htm DEFA14A Document

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    SCHEDULE 14A
    PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE
    SECURITIES EXCHANGE ACT OF 1934

    Filed by the Registrant ☒

    Filed by a Party other than the Registrant ☐

    Check the appropriate box:

    ☐Preliminary Proxy Statement

    ☐Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

    ☐Definitive Proxy Statement

    ☒Definitive Additional Materials

    ☐Soliciting Material Pursuant to §240.14a-12

    Pacific Biosciences of California, Inc.
    (Name of Registrant as Specified In Its Charter)

    Payment of Filing Fee (Check the appropriate box):

    ☒No fee required

    ☐Fee paid previously with preliminary materials

    ☐Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11






    final2024_annualxshareholda.jpg



    final2024_annualxshareholdb.jpg



    final2024_annualxsharehold.jpg



    final2024_annualxshareholdc.jpg



    final2024_annualxshareholdh.jpg



    final2024_annualxshareholdi.jpg



    final2024_annualxshareholdd.jpg



    final2024_annualxshareholdj.jpg



    final2024_annualxshareholde.jpg



    final2024_annualxshareholdf.jpg



    final2024_annualxshareholdm.jpg



    final2024_annualxshareholdn.jpg



    final2024_annualxshareholdk.jpg



    final2024_annualxshareholdo.jpg



    final2024_annualxshareholdl.jpg



    final2024_annualxshareholdg.jpg

    Get the next $PACB alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $PACB

    DatePrice TargetRatingAnalyst
    11/11/2024Buy → Neutral
    UBS
    6/3/2024$4.00Buy
    Jefferies
    4/22/2024Overweight → Neutral
    JP Morgan
    4/18/2024$7.00 → $2.50Buy → Neutral
    Goldman
    12/14/2023$11.00Overweight
    Stephens
    12/14/2023Neutral
    Guggenheim
    12/13/2023Peer Perform
    Wolfe Research
    11/17/2023$13.00 → $10.00Neutral → Buy
    UBS
    More analyst ratings

    $PACB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Pacific Biosciences downgraded by UBS

      UBS downgraded Pacific Biosciences from Buy to Neutral

      11/11/24 9:44:33 AM ET
      $PACB
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Jefferies resumed coverage on Pacific Biosciences with a new price target

      Jefferies resumed coverage of Pacific Biosciences with a rating of Buy and set a new price target of $4.00

      6/3/24 8:16:36 AM ET
      $PACB
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Pacific Biosciences downgraded by JP Morgan

      JP Morgan downgraded Pacific Biosciences from Overweight to Neutral

      4/22/24 7:40:44 AM ET
      $PACB
      Biotechnology: Laboratory Analytical Instruments
      Industrials